Site Search
Search Results
Texas Becomes Latest State to Improve Access to Biomarker Testing, Beating New York in Push to Prioritize Precision Medicine
... TX – MAY 30, 2023 – Yesterday, Texas Governor Greg Abbott signed Senate Bill 989 into law, making Texas the 11 th state to expand access to biomarker testing. New York is considering comparable legislation through Assembly Bill 1673 / Senate Bill 1196. The American Cancer Society Cancer Action ... responded to the legislative victory in Texas with the following statement: “Texas has joined a growing list of states expanding access to biomarker testing. The clock is ticking for New York to do the same. We cannot wait any longer to act on Assembly Bill 1673 / Senate Bill 1196. ...
Legislation Aimed at Improving Health Outcomes for New Yorkers Awaits Governor's Action
ALBANY, NY – JUNE 9, 2023 – Late last night, the New York State Assembly passed Assembly Bill 1673a to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The bill will now go to Governor Hochul’s desk, providing her the ... (ACS CAN) is sponsoring this significant policy change to ensure more cancer patients can get the testing needed to access precision medicine. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that can lead to ...
Governor Hochul Signs Game-Changing Legislation Aimed at Improving Health Outcomes, Quality of Life for New Yorkers
... a major win for patients across New York. The new law will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, which will enable more New Yorkers to access precision medicine treatments that can lead to fewer side effects, improved survival, better ... fight against cancer and improve access to the most effective treatments, giving patients a better chance of living longer, healthier lives.” Biomarker testing has become a game-changing part of cancer care given its role in opening the door to personalized care, including targeted ...
Colorectal Cancer Awareness Month 2023: What Has New York Done to Address Rise in Colorectal Cancer Diagnoses?
... the New York State Legislature aims to improve access to precision medicine for patients with cancer and other diseases by expanding access to biomarker testing. Building off the progress of the Colorectal Cancer Cost-Sharing Removal Act, which was passed at the end of 2022 and will remove financial barriers to screening, Senate Bill 1196 / Assembly Bill 1673 will ensure that New Yorkers who could benefit from biomarker testing have access to it, including those with CRC. The proposed legislation will require all state-regulated health plans, including ...
Legislation Aimed at Improving Health Outcomes for New Yorkers Heads to Governor Hochul’s Desk
... proposal aims to ensure millions of New Yorkers can access precision care by requiring all state-regulated health plans to cover comprehensive biomarker testing. Biomarker testing opens the door to treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower ...
**MEDIA ADVISORY – RALLY **
... on Tuesday, April 25 to ask legislators to support Senate Bill 1196 / Assembly Bill 1673, which aims to improve New Yorkers’ access to biomarker testing – a tool that opens the door to precision medicine. WHAT: ACS CAN New York Cancer Action Day WHO: Over 160 cancer survivors, caregivers and patient advocates representing ACS CAN to rally around biomarker testing legislation WHERE: The Well, New York State Legislative Office Building WHEN: Tuesday, April 25, 11:15 am ...
Lawmakers can improve the odds in New Yorkers' battles against cancer
... burden of their diagnosis. The next step in minimizing cancer’s burden should be to ensure that New Yorkers who could benefit have access to biomarker testing--a critical component of precision medicine. The results of these biomarker tests can help match patients with the right treatment at the right time. Recent studies show that biomarker testing can improve outcomes ...
Cervical Cancer Awareness Month 2023: New York Ranks Fourth in Cervical Cancer Deaths among States
... lost in 2017, New York would recover definitive gaps in access to early detection services for cervical cancer. 2. Expand access to biomarker testing for patients covered by state-regulated health plans, including Medicaid. Insight gained from biomarker testing can be used to help guide medical treatment in cervical and other cancers. Biomarker testing is often used to connect patients ...
Steps Governor Hochul Can Take to Make New York a Leader in Health Equity
... a bold step in health policy and greater accessibility to precision medicine technologies. ACS CAN proposes that New York improve access to biomarker testing—a technology that enables oncologists to provide the right treatment for the right patient at the right time. Allowing oncologists to ... treatment with precision medicine can lead to better outcomes. Right now, not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Many health insurance plans in New York, including Medicaid, may not cover the most appropriate biomarker ...
New York Patient Navigation Campaign
... email updates about the campaign complete this form. Share your Story A patients story is the most impactful way to convey the importance of biomarker testing. Do you have a story to share? If you are a patient or survivor battling a disease or chronic illness like cancer who has had biomarker testing and benefitted from a targeted therapy because of that testing, please fill out this survey form and share your story with ...